U.S. markets closed

NuCana plc (NCNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.6500+0.0200 (+1.23%)
At close: 04:00PM EDT
1.6700 +0.02 (+1.21%)
After hours: 05:51PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close1.6300
Bid1.6200 x 900
Ask1.6700 x 1200
Day's Range1.5500 - 1.6800
52 Week Range0.5170 - 3.3200
Avg. Volume319,546
Market Cap86.123M
Beta (5Y Monthly)1.22
PE Ratio (TTM)N/A
EPS (TTM)-0.9200
Earnings DateAug 17, 2022 - Aug 22, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est762.88
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for NCNA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NuCana plc
    Analyst Report: Pfizer Inc.Pfizer is a leading global developer and manufacturer of pharmaceuticals and biotech drugs. Its products include oncology and immunology drugs, treatments for rare diseases, and vaccines.
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • GlobeNewswire

    NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement

    EDINBURGH, United Kingdom, July 27, 2022 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA), (“NuCana” or the “Company”), announced that it has received a written notification (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”) and the matter is

  • Simply Wall St.

    Here's What NuCana plc's (NASDAQ:NCNA) Shareholder Ownership Structure Looks Like

    Every investor in NuCana plc ( NASDAQ:NCNA ) should be aware of the most powerful shareholder groups. Institutions will...

  • Benzinga

    Why NuCana Shares Are Rising Today?

    Regional Court of Dusseldorf has ruled in favor of NuCana plc (NASDAQ: NCNA), stating that Gilead Sciences Ireland UC and Gilead Sciences GmbH infringed NuCana's composition of matter claims in European Patent 2955190 through their sales of Sovaldi, Harvoni, Vosevi and Epclusa in Germany. This judgment follows Gilead's unsuccessful challenge to the validity of NuCana's ‘190 patent at the Opposition Division of the European Patent Office in 2021. Gilead also attempted to challenge the validity of